BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 31346968)

  • 1. A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
    Zhang C; Hu R; Zhang G; Zhe Y; Hu B; He J; Wang Z; Qi X
    J Mol Neurosci; 2019 Nov; 69(3):433-443. PubMed ID: 31346968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population.
    Xiao Q; Liu ZJ; Tao S; Sun YM; Jiang D; Li HL; Chen H; Liu X; Lapin B; Wang CH; Zheng SL; Xu J; Wu ZY
    Oncotarget; 2015 Nov; 6(35):36955-64. PubMed ID: 26543236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model.
    Li H; Yang L; Zhao X; Wang J; Qian J; Chen H; Fan W; Liu H; Jin L; Wang W; Lu D
    BMC Med Genet; 2012 Dec; 13():118. PubMed ID: 23228068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
    Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
    Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease.
    Shi Z; Yu H; Wu Y; Ford M; Perschon C; Wang C; Zheng SL; Xu J
    Clin Genet; 2019 Feb; 95(2):302-309. PubMed ID: 30460685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic risk of Alzheimer's disease in the Faroe Islands.
    Johansen M; Joensen S; Restorff M; Stórá T; Christy D; Gustavsson EK; Bian J; Guo Y; Farrer MJ; Petersen MS
    Eur J Neurol; 2022 Aug; 29(8):2192-2200. PubMed ID: 35384166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.
    Chouraki V; Reitz C; Maury F; Bis JC; Bellenguez C; Yu L; Jakobsdottir J; Mukherjee S; Adams HH; Choi SH; Larson EB; Fitzpatrick A; Uitterlinden AG; de Jager PL; Hofman A; Gudnason V; Vardarajan B; Ibrahim-Verbaas C; van der Lee SJ; Lopez O; Dartigues JF; Berr C; Amouyel P; Bennett DA; van Duijn C; DeStefano AL; Launer LJ; Ikram MA; Crane PK; Lambert JC; Mayeux R; Seshadri S;
    J Alzheimers Dis; 2016 Jun; 53(3):921-32. PubMed ID: 27340842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of gene polymorphisms of CD36 and ApoE with susceptibility of Alzheimer disease: A case-control study.
    Zhou L; Li HY; Wang JH; Deng ZZ; Shan YL; Tan S; Shi YH; Zhang MX; Liu SX; Zhang BJ; Hong MF; Lu ZQ; Huang XM
    Medicine (Baltimore); 2018 Sep; 97(38):e12470. PubMed ID: 30235742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.
    Elcoroaristizabal Martín X; Fernández Martínez M; Galdos Alcelay L; Molano Salazar A; Bereincua Gandarias R; Inglés Borda S; Gómez Busto F; Uterga Valiente JM; Indakoetxea Juanbeltz B; Gómez Beldarraín MA; de Pancorbo MM
    Dement Geriatr Cogn Disord; 2011; 32(5):332-41. PubMed ID: 22311091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic risk score combining ten psoriasis risk loci improves disease prediction.
    Chen H; Poon A; Yeung C; Helms C; Pons J; Bowcock AM; Kwok PY; Liao W
    PLoS One; 2011 Apr; 6(4):e19454. PubMed ID: 21559375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.
    Desikan RS; Fan CC; Wang Y; Schork AJ; Cabral HJ; Cupples LA; Thompson WK; Besser L; Kukull WA; Holland D; Chen CH; Brewer JB; Karow DS; Kauppi K; Witoelar A; Karch CM; Bonham LW; Yokoyama JS; Rosen HJ; Miller BL; Dillon WP; Wilson DM; Hess CP; Pericak-Vance M; Haines JL; Farrer LA; Mayeux R; Hardy J; Goate AM; Hyman BT; Schellenberg GD; McEvoy LK; Andreassen OA; Dale AM
    PLoS Med; 2017 Mar; 14(3):e1002258. PubMed ID: 28323831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease genes and cognition in the nondemented general population.
    Verhaaren BF; Vernooij MW; Koudstaal PJ; Uitterlinden AG; van Duijn CM; Hofman A; Breteler MM; Ikram MA
    Biol Psychiatry; 2013 Mar; 73(5):429-34. PubMed ID: 22592056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease.
    Chaudhury S; Patel T; Barber IS; Guetta-Baranes T; Brookes KJ; Chappell S; Turton J; Guerreiro R; Bras J; Hernandez D; Singleton A; Hardy J; Mann D; ; Morgan K
    Neurobiol Aging; 2018 Feb; 62():244.e1-244.e8. PubMed ID: 29103623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42.
    Sleegers K; Bettens K; De Roeck A; Van Cauwenberghe C; Cuyvers E; Verheijen J; Struyfs H; Van Dongen J; Vermeulen S; Engelborghs S; Vandenbulcke M; Vandenberghe R; De Deyn PP; Van Broeckhoven C;
    Alzheimers Dement; 2015 Dec; 11(12):1452-1460. PubMed ID: 26086184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic Risk Score Analysis of Alzheimer's Disease in Cases without APOE4 or APOE2 Alleles.
    Escott-Price V; Myers A; Huentelman M; Shoai M; Hardy J
    J Prev Alzheimers Dis; 2019; 6(1):16-19. PubMed ID: 30569081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential genetic biomarkers in the early diagnosis of Alzheimer disease: APOE and BIN1.
    Kaya G; Gündüz E; Acar M; Hatipoğlu ÖF; Acar B; Ilhan A; Gündüz M
    Turk J Med Sci; 2015; 45(5):1058-72. PubMed ID: 26738348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Alzheimer's disease risk variants identified based on whole-genome sequencing of APOE ε4 carriers.
    Park JH; Park I; Youm EM; Lee S; Park JH; Lee J; Lee DY; Byun MS; Lee JH; Yi D; Chung SJ; Park KW; Choi N; Kim SY; Yoon W; An H; Kim KW; Choi SH; Jeong JH; Kim EJ; Kang H; Lee J; Kim Y; Lee EA; Seo SW; Na DL; Kim JW
    Transl Psychiatry; 2021 May; 11(1):296. PubMed ID: 34011927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE genotypes in Lebanon: distribution and association with hypercholesterolemia and Alzheimer's disease.
    El Shamieh S; Costanian C; Kassir R; Visvkis-Siest S; Bissar-Tadmouri N
    Per Med; 2019 Jan; 16(1):15-23. PubMed ID: 30457419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
    van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
    Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.